课题基金 / 基金详情

Title: Conformational dynamics and protein folding/misfolding of alpha1-antitrypsin studied by state-of-the-art tandem ion mobility mass spectrometry

Title: Conformational dynamics and protein folding/misfolding of alpha1-antitrypsin studied by state-of-the-art tandem ion mobility mass spectrometry
标题:通过最先进的串联离子淌度质谱法研究 α1-抗胰蛋白酶的构象动力学和蛋白质折叠/错误折叠
批准号:
2414124
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
我们将研究蛋白质α 1-抗胰蛋白酶(A1 AT)的构象动力学和寡聚化。我们将详细研究A1 AT序列变体的影响,并详细分析糖基化模式及其对构象/寡聚化的影响。因此,该项目完全符合DTP疾病主题的基本机制。除了使用更成熟的生物化学和生物物理表征,我们将研究这些过程中使用一种新的循环离子迁移率质谱仪(cIMMS)。UCL是世界上第三个安装cIMMS的地方,在2019年12月,Thalassinos实验室是世界上第一个发表手稿展示cIMMS如何用于研究天然蛋白质结构的实验室(Eldrid等人)。这非常抢先体验的Thalassinos实验室,以这种新技术是由以前的CASE博士生促进,清楚地展示了这些类型的奖学金的重要性,使尖端技术的学术界。蛋白A1 AT是最丰富的循环蛋白酶抑制剂。它在肝细胞ER中合成,其关键靶标是中性粒细胞弹性蛋白酶。A1 AT的突变导致其聚合,具有功能效应的丧失和获得。肝脏中积累的聚合物导致肝硬化,而循环A1 AT的缺乏使肺暴露于不受控制的弹性蛋白酶活性,易患肺气肿。糖基化对蛋白质构象和聚集倾向的影响迄今尚未详细研究。A1 AT具有三个含有复杂N-聚糖结构的糖基化位点。一个主要的挑战是糖基化模式的异质性,以及每个位点的多个可能的聚糖占据。这对现有的结构和生物物理方法提出了挑战,因为几乎所有这些方法都报告了总体平均值。相反,离子迁移率质谱(IMMS)是详细研究非均相样品和分离特定构象以供进一步研究的极好方法。新的cIMMS设备不仅提供了很大的改善,以解决能力相比,以前的IMMS仪器,但也由于其独特的设计将使我们能够分离密切相关的构象进一步更高的分辨率(串联离子迁移率)构象分析,我们将使用cIMMS分析不同糖基化模式对A1 AT蛋白的影响,构象、动力学和低聚倾向。我们还将用它来探测前所未有的细节连接聚糖的性质。IMMS可以从极少量的材料中分离聚糖异构体,这是生物学研究的理想选择,特别是涉及患者材料的研究。学生将在Lomas实验室接受A1 AT样品分离,制备和生物物理表征的培训,并在Thalassinos实验室接受IMMS的使用培训。参观沃茨将提供cIMMS设备使用方面的进一步培训,以及目前在威姆斯洛沃茨开发的其他尖端技术。我们预计,任何发现和开发的方法都适用于其他构象疾病,这些疾病在老龄化人群中的发病率会因蛋白质稳态的破坏而增加,并且迄今为止难以通过其他现有技术进行研究。
英文摘要
We will study the conformational dynamics and oligomerisation of the protein alpha1-antitrypsin (A1AT). We will examine in detail the effect of A1AT sequence variants and also characterise in detail the glycosylation patterns and the effect they have on conformation/oligomerisation. This project is therefore completely aligned with the fundamental mechanisms of disease theme of the DTP. In addition to using more established biochemical and biophysical characterisation, we will study such processes using a novel cyclic ion mobility mass spectrometer (cIMMS). UCL is the 3rd place in the world to have a cIMMS installed, in Dec 2019, and the Thalassinos lab has been the first worldwide to publish a manuscript showcasing how the cIMMS can be used to study native protein structure (Eldrid et al.). This very early access of the Thalassinos lab to this novel technology was facilitated by a previous CASE PhD student, clearly showcasing the importance of these types of studentships for bringing cutting edge technology to academia.The protein A1AT is the most abundant circulating protease inhibitor. It is synthesised in the hepatocyte ER and its key target is the enzyme neutrophil elastase. Mutations in A1AT cause it to polymerise, with both loss and gain of function effects. Polymers accumulated in the liver cause cirrhosis while the lack of circulating A1AT exposes the lungs to uncontrolled elastase activity, predisposing to emphysema. The effect of glycosylation on protein conformation and aggregation propensity has so far not been studied in detail. A1AT has three glycosylation sites containing complex N-glycan structures. A major challenge is the heterogeneity in the glycosylation patterns in addition to multiple possible glycan occupancy at each site. This poses a challenge to established structural and biophysical methods as almost all of them report on ensemble averages. Ion mobility mass spectrometry (IMMS), on the contrary, is an excellent method for studying in detail heterogeneous samples and for isolating particular conformers for further study. The new cIMMS device not only offers great improvements into the resolving power compared to previous IMMS instrumentation but also due to its unique design will allow us to isolate closely related conformers for further higher resolution (tandem ion mobility) conformational analysis, something not possible with any other commercial IMMS instrumentation.We will use the cIMMS to both analyse the effect of different glycosylation patterns on A1AT protein conformation, dynamics and propensity to oligomerise. We will also use it to probe in unprecedented detail the nature of the attached glycans. IMMS can separate glycan isomers from very low amounts of material, something desirable for biological studies, especially those involving patient material.The student will be trained in A1AT sample isolation, preparation and biophysical characterisation in the Lomas lab and in the use of IMMS in the Thalassinos lab. Visits to Waters will provide further training in the use of the cIMMS devise but also in additional cutting-edge technology currently under development at Waters in Wilmslow.We anticipate any findings, and methods developed, to be applicable to other conformational diseases whose incidence increases in ageing populations due to breakdown of protein homeostasis and which have so far been intractable to study by other established techniques.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金